Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dakshnapriya Balasubbramanian

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Perspectives in Medicine|March 15, 2022
Lymphatics in Cardiovascular PhysiologyDakshnapriya Balasubbramanian, Brett M Mitchell
Pharmacological Research|April 19, 2017
Toll-like receptor activation, vascular endothelial function, and hypertensive disorders of pregnancyDakshnapriya Balasubbramanian, Catalina A Lopez Gelston, Brett M Mitchell, et al.
British Journal of Pharmacology|May 26, 2018
Immune cell trafficking, lymphatics and hypertensionDakshnapriya Balasubbramanian, Catalina A Lopez Gelston, Joseph M Rutkowski, et al.
Journal of Hypertension|January 9, 2020
Kidney-specific lymphangiogenesis increases sodium excretion and lowers blood pressure in miceDakshnapriya Balasubbramanian, Gaurav Baranwal, Mary-Catherine C Clark, et al.
American Journal of Hypertension|August 21, 2019
Augmenting Renal Lymphatic Density Prevents Angiotensin II-Induced Hypertension in Male and Female MiceDakshnapriya Balasubbramanian, Catalina A Lopez Gelston, Alexandra H Lopez, et al.
Circulation Research|February 25, 2018
Enhancing Renal Lymphatic Expansion Prevents Hypertension in MiceCatalina A Lopez Gelston, Dakshnapriya Balasubbramanian, Gabriella R Abouelkheir, et al.
Clinical Science (London, England : 1979)|November 8, 2022
Genetically inducing renal lymphangiogenesis attenuates hypertension in miceBethany L Goodlett, Dakshnapriya Balasubbramanian, Shobana Navaneethabalakrishnan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2015
Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosisJoe A Arosh, JeHoon Lee, Dakshnapriya Balasubbramanian, et al.
Pharmaceutics|January 21, 2022
A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive MiceBethany L Goodlett, Chang Sun Kang, Eunsoo Yoo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Medicine|March 15, 2022
Lymphatics in Cardiovascular PhysiologyDakshnapriya Balasubbramanian, Brett M Mitchell
Pharmacological Research|April 19, 2017
Toll-like receptor activation, vascular endothelial function, and hypertensive disorders of pregnancyDakshnapriya Balasubbramanian, Catalina A Lopez Gelston, Brett M Mitchell, et al.
British Journal of Pharmacology|May 26, 2018
Immune cell trafficking, lymphatics and hypertensionDakshnapriya Balasubbramanian, Catalina A Lopez Gelston, Joseph M Rutkowski, et al.
Journal of Hypertension|January 9, 2020
Kidney-specific lymphangiogenesis increases sodium excretion and lowers blood pressure in miceDakshnapriya Balasubbramanian, Gaurav Baranwal, Mary-Catherine C Clark, et al.
American Journal of Hypertension|August 21, 2019
Augmenting Renal Lymphatic Density Prevents Angiotensin II-Induced Hypertension in Male and Female MiceDakshnapriya Balasubbramanian, Catalina A Lopez Gelston, Alexandra H Lopez, et al.
Circulation Research|February 25, 2018
Enhancing Renal Lymphatic Expansion Prevents Hypertension in MiceCatalina A Lopez Gelston, Dakshnapriya Balasubbramanian, Gabriella R Abouelkheir, et al.
Clinical Science (London, England : 1979)|November 8, 2022
Genetically inducing renal lymphangiogenesis attenuates hypertension in miceBethany L Goodlett, Dakshnapriya Balasubbramanian, Shobana Navaneethabalakrishnan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2015
Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosisJoe A Arosh, JeHoon Lee, Dakshnapriya Balasubbramanian, et al.
Pharmaceutics|January 21, 2022
A Kidney-Targeted Nanoparticle to Augment Renal Lymphatic Density Decreases Blood Pressure in Hypertensive MiceBethany L Goodlett, Chang Sun Kang, Eunsoo Yoo, et al.
Pageof 1